News

What Is A Live Stock/Share and How To Buy Them?

A live stock is a paper security issued by a stock company, in other words, an issuing company. All the investors who bought the shares became co-owners of the company. The action just confirms that its owner has a stake in the company, even if it is very small. What are the types of live…

4 Methods to Save on Meds and 4 Facts about US and Canadian Pharmacies

For several years in a row, drug prices have shown enviable stability, and, in 2020-2021, they increased considerably. Available programs are an opportunity to save on the purchase of medications. In addition, there are so many aspects to buy affordable medications either online or offline. Let’s consider the main methods on how to save on…

Why to Buy Drugs Online – A Customer Review

Many people ask why I am not a fan of classic conventional drugstores and I am ready to get the answer. My name is April and I am fond of online pharmacies. I have several top online pharmacies but today I will speak about My Canadian Pharmacy. I hope at the end of this review,…

American Stock Exchange Accepts Callisto Pharamceuticals’ Plan of Compliance and Extension to Regain Compliance with Standards

NEW YORK, Aug. 29, 2007 /PRNewswire-FirstCall/ — Callisto Pharmaceuticals, Inc. (Amex: KAL – News; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders and diseases,  today announced that the staff of the American Stock Exchange (“AMEX”) has reviewed the Company’s plan of compliance to meet the AMEX’s continued…

Callisto Reports on Second-Quarter 2007 Milestones

NEW YORK, August 8 /PRNewswire-FirstCall/ — Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal diseases, is pleased to provide  an update covering its strategic and drug development activities for the second quarter of 2007. “Callisto has made substantial progress with our clinical and…

Callisto Pharmaceuticals Raises $11.2 Million in Series B Preferred Stock Financing

NEW YORK, Aug. 7 /PRNewswire-FirstCall/ — Callisto Pharmaceuticals, Inc. (Amex: KAL – News; FWB: CA4), a biopharmaceutical company primarily focused on the development of  new drugs to treat cancer and gastrointestinal diseases, announced today that it has closed a private placement of 1,124,550 shares of Series B Convertible Preferred Stock and 22,491,000 warrants for aggregate…